Of note, the therapeutic effect of uPAR-specific CAR T cells on liver fibrosis in mice with nonalcoholic fatty liver disease (NAFLD) was remarkable due to the elimination of senescent hepatocytes (84). The gene discussed is PLAUR; the disease is metabolic dysfunction-associated steatotic liver disease.